November 28, 2018 Posted By Categories This guest post is by Earle Holland, a member of our editorial team for the past four years. For almost 35 years, he was the senior science and medical communications officer at Ohio State University. He is a fellow of the American Association for the Advancement of Science. Earlier this week,… Read More »
A new paper published by McGill University researchers in JAMA Internal Medicine suggests that some clinical trials may promote the use of ineffective and costly treatments. That’s the opposite of what clinical trials are aimed at, namely preventing ineffective and costly treatments from being taken up by physicians and patients. The researchers focused their attention… Read More »
Alphabet’s DeepMind, the UK-based health and artificial intelligence company, is merging part of its business back into Google.
November 12th, 2018 Editors Nuclear Medicine, Oncology, Public Health, Radiation Oncology, Radiology Medical radioisotopes are widely used in cancer treatment, but their production has been hampered to the point that obtaining them has become a challenge. The lack of Technetium-99m is probably the most widely known, but there’s also a shortage of Iodine-131 (I-131), a radioisotope… Read More »
Scripps Research Translational Institute and NVIDIA will collaborate to create deep learning tools aimed at deriving actionable insights from genomic and medical sensor data. The initiative aims to bring artificial intelligence to process large amounts of data that the partners expect to be gathered through the emerging use of such data in diagnosis, personalized treatment… Read More »